Novel motif:17: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:34, 9 September 2013
name: | motif17_CGCTAN |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0000398 | nuclear mRNA splicing, via spliceosome | 1.060318e-12 |
GO:0000375 | RNA splicing, via transesterification reactions | 4.407971e-12 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 6.056491e-11 |
GO:0008272 | sulfate transport | 6.297564e-11 |
GO:0006353 | transcription termination, DNA-dependent | 3.444811e-10 |
GO:0006289 | nucleotide-excision repair | 7.149853e-10 |
GO:0000413 | protein peptidyl-prolyl isomerization | 2.069235e-9 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 2.307028e-9 |
GO:0006354 | transcription elongation, DNA-dependent | 5.781753e-9 |
GO:0010999 | regulation of eIF2 alpha phosphorylation by heme | 1.460469e-8 |
GO:0009589 | detection of UV | 1.460469e-8 |
GO:0032425 | positive regulation of mismatch repair | 1.911162e-8 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 2.047792e-8 |
GO:0006396 | RNA processing | 2.646895e-8 |
GO:0070127 | tRNA aminoacylation for mitochondrial protein translation | 2.879320e-8 |
GO:0070145 | mitochondrial asparaginyl-tRNA aminoacylation | 4.423798e-8 |
GO:0006360 | transcription from RNA polymerase I promoter | 5.421558e-8 |
GO:0050434 | positive regulation of viral transcription | 8.594656e-8 |
GO:0071423 | malate transmembrane transport | 1.068597e-7 |
GO:0015709 | thiosulfate transport | 1.068597e-7 |
GO:0006363 | termination of RNA polymerase I transcription | 1.492514e-7 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 1.888980e-7 |
GO:0018208 | peptidyl-proline modification | 4.194932e-7 |
GO:0032543 | mitochondrial translation | 5.760991e-7 |
GO:0000959 | mitochondrial RNA metabolic process | 8.748660e-7 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 9.253979e-7 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 1.086523e-6 |
GO:0032423 | regulation of mismatch repair | 1.170444e-6 |
GO:0016071 | mRNA metabolic process | 1.269504e-6 |
GO:0008380 | RNA splicing | 2.278977e-6 |
GO:0046782 | regulation of viral transcription | 2.350287e-6 |
GO:0006370 | mRNA capping | 3.732743e-6 |
GO:0018364 | peptidyl-glutamine methylation | 4.625236e-6 |
GO:0006397 | mRNA processing | 6.007310e-6 |
GO:0035883 | enteroendocrine cell differentiation | 6.357998e-6 |
GO:0048339 | paraxial mesoderm development | 9.386368e-6 |
GO:0021591 | ventricular system development | 9.824088e-6 |
GO:0015761 | mannose transport | 1.402059e-5 |
GO:0009452 | RNA capping | 1.402071e-5 |
GO:0021670 | lateral ventricle development | 1.569917e-5 |
GO:0031627 | telomeric loop formation | 1.628915e-5 |
GO:0006399 | tRNA metabolic process | 1.870218e-5 |
GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly | 1.888018e-5 |
GO:0016032 | viral reproduction | 2.005638e-5 |
GO:0043441 | acetoacetic acid biosynthetic process | 2.508275e-5 |
GO:0016926 | protein desumoylation | 2.555038e-5 |
GO:0030206 | chondroitin sulfate biosynthetic process | 2.558339e-5 |
GO:0048341 | paraxial mesoderm formation | 2.777398e-5 |
GO:0035545 | determination of left/right asymmetry in nervous system | 3.043464e-5 |
GO:0032790 | ribosome disassembly | 3.235545e-5 |
GO:0018023 | peptidyl-lysine trimethylation | 3.238524e-5 |
GO:0072329 | monocarboxylic acid catabolic process | 4.094247e-5 |
GO:0043039 | tRNA aminoacylation | 4.202282e-5 |
GO:0000216 | M/G1 transition of mitotic cell cycle | 4.286811e-5 |
GO:0006405 | RNA export from nucleus | 4.766133e-5 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 5.261235e-5 |
GO:0046501 | protoporphyrinogen IX metabolic process | 5.879114e-5 |
GO:0046358 | butyrate biosynthetic process | 7.780695e-5 |
GO:0006261 | DNA-dependent DNA replication | 8.198097e-5 |
GO:0007635 | chemosensory behavior | 8.695021e-5 |
GO:0061157 | mRNA destabilization | 8.856015e-5 |
GO:0010609 | posttranscriptional regulation of gene expression by mRNA localization | 8.856015e-5 |
GO:0006421 | asparaginyl-tRNA aminoacylation | 9.559730e-5 |
GO:0006406 | mRNA export from nucleus | 1.053516e-4 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 1.068774e-4 |
GO:0019348 | dolichol metabolic process | 1.068774e-4 |
GO:0046086 | adenosine biosynthetic process | 1.088657e-4 |
GO:0048291 | isotype switching to IgG isotypes | 1.149071e-4 |
GO:0032900 | negative regulation of neurotrophin production | 1.149071e-4 |
GO:0002368 | B cell cytokine production | 1.149071e-4 |
GO:0032244 | positive regulation of nucleoside transport | 1.149071e-4 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 1.149071e-4 |
GO:0042228 | interleukin-8 biosynthetic process | 1.168631e-4 |
GO:0050689 | negative regulation of defense response to virus by host | 1.314009e-4 |
GO:0006457 | protein folding | 1.343476e-4 |
GO:0042168 | heme metabolic process | 1.485505e-4 |
GO:0048524 | positive regulation of viral reproduction | 1.528125e-4 |
GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process | 1.551621e-4 |
GO:0060486 | Clara cell differentiation | 1.614071e-4 |
GO:0051320 | S phase | 1.634049e-4 |
GO:0006525 | arginine metabolic process | 1.659828e-4 |
GO:0009062 | fatty acid catabolic process | 1.776400e-4 |
GO:0060087 | relaxation of vascular smooth muscle | 1.870849e-4 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 1.931631e-4 |
GO:0042696 | menarche | 1.945761e-4 |
GO:0032074 | negative regulation of nuclease activity | 2.030694e-4 |
GO:0006352 | transcription initiation, DNA-dependent | 2.052748e-4 |
GO:0022616 | DNA strand elongation | 2.275230e-4 |
GO:0046395 | carboxylic acid catabolic process | 2.299918e-4 |
GO:0050779 | RNA destabilization | 2.327836e-4 |
GO:0034660 | ncRNA metabolic process | 2.354498e-4 |
GO:0046950 | cellular ketone body metabolic process | 2.385174e-4 |
GO:0006423 | cysteinyl-tRNA aminoacylation | 2.634420e-4 |
GO:0043248 | proteasome assembly | 2.933495e-4 |
GO:0006783 | heme biosynthetic process | 2.998288e-4 |
GO:0000084 | S phase of mitotic cell cycle | 3.004029e-4 |
GO:0035845 | photoreceptor cell outer segment organization | 3.325455e-4 |
GO:0010452 | histone H3-K36 methylation | 3.384574e-4 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 3.403565e-4 |
GO:0030208 | dermatan sulfate biosynthetic process | 3.547421e-4 |
GO:0021542 | dentate gyrus development | 3.591491e-4 |
GO:0006390 | transcription from mitochondrial promoter | 3.832562e-4 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 3.871403e-4 |
GO:0006369 | termination of RNA polymerase II transcription | 3.929832e-4 |
GO:0019264 | glycine biosynthetic process from serine | 4.172644e-4 |
GO:0042538 | hyperosmotic salinity response | 4.280955e-4 |
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 4.598455e-4 |
GO:0051790 | short-chain fatty acid biosynthetic process | 4.605315e-4 |
GO:0046416 | D-amino acid metabolic process | 4.879431e-4 |
GO:0048340 | paraxial mesoderm morphogenesis | 4.912757e-4 |
GO:0006271 | DNA strand elongation involved in DNA replication | 4.924004e-4 |
GO:0030826 | regulation of cGMP biosynthetic process | 4.970184e-4 |
GO:0046105 | thymidine biosynthetic process | 5.186993e-4 |
GO:0016598 | protein arginylation | 5.186993e-4 |
GO:0021759 | globus pallidus development | 5.192250e-4 |
GO:0000723 | telomere maintenance | 5.262665e-4 |
GO:0042503 | tyrosine phosphorylation of Stat3 protein | 5.563521e-4 |
GO:0046951 | ketone body biosynthetic process | 6.019270e-4 |
GO:0048343 | paraxial mesodermal cell fate commitment | 6.333968e-4 |
GO:0032119 | sequestering of zinc ion | 6.475546e-4 |
GO:0007263 | nitric oxide mediated signal transduction | 6.759511e-4 |
GO:0000244 | assembly of spliceosomal tri-snRNP | 6.790549e-4 |
GO:0006418 | tRNA aminoacylation for protein translation | 6.845323e-4 |
GO:0003310 | pancreatic A cell differentiation | 6.936181e-4 |
GO:0018352 | protein-pyridoxal-5-phosphate linkage | 7.499614e-4 |
GO:0006458 | 'de novo' protein folding | 7.594691e-4 |
GO:0015866 | ADP transport | 7.767828e-4 |
GO:0010836 | negative regulation of protein ADP-ribosylation | 7.808198e-4 |
GO:0070071 | proton-transporting two-sector ATPase complex assembly | 7.910874e-4 |
GO:0060972 | left/right pattern formation | 7.911010e-4 |
GO:0010833 | telomere maintenance via telomere lengthening | 8.654661e-4 |
GO:0071422 | succinate transmembrane transport | 8.801373e-4 |
GO:0010701 | positive regulation of norepinephrine secretion | 9.422102e-4 |
GO:0006781 | succinyl-CoA pathway | 9.559969e-4 |
GO:0006545 | glycine biosynthetic process | 1.002172e-3 |
GO:0032988 | ribonucleoprotein complex disassembly | 1.004015e-3 |
GO:0006024 | glycosaminoglycan biosynthetic process | 1.055419e-3 |
GO:0046813 | virion attachment, binding of host cell surface receptor | 1.097719e-3 |
GO:0006023 | aminoglycan biosynthetic process | 1.170074e-3 |
GO:0050965 | detection of temperature stimulus involved in sensory perception of pain | 1.172550e-3 |
GO:0017183 | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | 1.172550e-3 |
GO:0031123 | RNA 3'-end processing | 1.226393e-3 |
GO:0072553 | terminal button organization | 1.255075e-3 |
GO:0071544 | diphosphoinositol polyphosphate catabolic process | 1.255075e-3 |
GO:0070535 | histone H2A K63-linked ubiquitination | 1.255075e-3 |
GO:0021873 | forebrain neuroblast division | 1.261350e-3 |
GO:0035082 | axoneme assembly | 1.280846e-3 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 1.385127e-3 |
GO:0045116 | protein neddylation | 1.402208e-3 |
GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c | 1.403303e-3 |
GO:0009070 | serine family amino acid biosynthetic process | 1.410938e-3 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 1.523969e-3 |
GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation | 1.561503e-3 |
GO:0060455 | negative regulation of gastric acid secretion | 1.561503e-3 |
GO:0006189 | 'de novo' IMP biosynthetic process | 1.561503e-3 |
GO:0060929 | atrioventricular node cell fate commitment | 1.578053e-3 |
GO:0060928 | atrioventricular node cell development | 1.578053e-3 |
GO:0003168 | cardiac Purkinje fiber cell differentiation | 1.578053e-3 |
GO:0003342 | proepicardium development | 1.578053e-3 |
GO:0043538 | regulation of actin phosphorylation | 1.640221e-3 |
GO:0006270 | DNA-dependent DNA replication initiation | 1.644711e-3 |
GO:0060670 | branching involved in embryonic placenta morphogenesis | 1.660755e-3 |
GO:0003334 | keratinocyte development | 1.660755e-3 |
GO:0000173 | inactivation of MAPK activity involved in osmosensory signaling pathway | 1.683142e-3 |
GO:0046718 | entry of virus into host cell | 1.686299e-3 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 1.751672e-3 |
GO:0070673 | response to interleukin-18 | 1.769062e-3 |
GO:0010760 | negative regulation of macrophage chemotaxis | 1.797087e-3 |
GO:0014739 | positive regulation of muscle hyperplasia | 1.797087e-3 |
GO:0006797 | polyphosphate metabolic process | 1.797087e-3 |
GO:0045986 | negative regulation of smooth muscle contraction | 1.853867e-3 |
GO:0007100 | mitotic centrosome separation | 1.912578e-3 |
GO:0021526 | medial motor column neuron differentiation | 2.006452e-3 |
GO:0003326 | pancreatic A cell fate commitment | 2.006452e-3 |
GO:0003329 | pancreatic PP cell fate commitment | 2.006452e-3 |
GO:0032200 | telomere organization | 2.059015e-3 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 2.111094e-3 |
GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus | 2.146965e-3 |
GO:0042558 | pteridine-containing compound metabolic process | 2.244892e-3 |
GO:0035329 | hippo signaling cascade | 2.333158e-3 |
GO:0090329 | regulation of DNA-dependent DNA replication | 2.413222e-3 |
GO:0060510 | Type II pneumocyte differentiation | 2.453386e-3 |
GO:0010722 | regulation of ferrochelatase activity | 2.595492e-3 |
GO:0006409 | tRNA export from nucleus | 2.595492e-3 |
GO:0060487 | lung epithelial cell differentiation | 2.709959e-3 |
GO:0032981 | mitochondrial respiratory chain complex I assembly | 2.779042e-3 |
GO:0035499 | carnosine biosynthetic process | 2.790374e-3 |
GO:0006529 | asparagine biosynthetic process | 2.790374e-3 |
GO:0010983 | positive regulation of high-density lipoprotein particle clearance | 2.790374e-3 |
GO:0044091 | membrane biogenesis | 2.812371e-3 |
GO:0070647 | protein modification by small protein conjugation or removal | 2.825944e-3 |
GO:0018342 | protein prenylation | 2.847507e-3 |
GO:0007231 | osmosensory signaling pathway | 2.875875e-3 |
GO:0032600 | chemokine receptor transport out of membrane raft | 2.888733e-3 |
GO:0032913 | negative regulation of transforming growth factor beta3 production | 2.888733e-3 |
GO:0032597 | B cell receptor transport into membrane raft | 2.888733e-3 |
GO:0090042 | tubulin deacetylation | 3.040901e-3 |
GO:0097151 | positive regulation of inhibitory postsynaptic membrane potential | 3.040901e-3 |
GO:0032581 | ER-dependent peroxisome organization | 3.040901e-3 |
GO:0070846 | Hsp90 deacetylation | 3.040901e-3 |
GO:0006065 | UDP-glucuronate biosynthetic process | 3.255420e-3 |
GO:0072011 | glomerular endothelium development | 3.277270e-3 |
GO:0072144 | glomerular mesangial cell development | 3.277270e-3 |
GO:0090234 | regulation of kinetochore assembly | 3.285813e-3 |
GO:0090169 | regulation of spindle assembly | 3.285813e-3 |
GO:0006644 | phospholipid metabolic process | 3.401884e-3 |
GO:0006356 | regulation of transcription from RNA polymerase I promoter | 3.461002e-3 |
GO:0060669 | embryonic placenta morphogenesis | 3.623824e-3 |
GO:0021869 | forebrain ventricular zone progenitor cell division | 3.664645e-3 |
GO:0002098 | tRNA wobble uridine modification | 3.677062e-3 |
GO:0034227 | tRNA thio-modification | 3.677062e-3 |
GO:0021986 | habenula development | 3.709247e-3 |
GO:0034970 | histone H3-R2 methylation | 3.787466e-3 |
GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway | 3.825243e-3 |
GO:0070682 | proteasome regulatory particle assembly | 3.926211e-3 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 3.979612e-3 |
GO:0021658 | rhombomere 3 morphogenesis | 3.983738e-3 |
GO:0016070 | RNA metabolic process | 4.165672e-3 |
GO:0006563 | L-serine metabolic process | 4.201490e-3 |
GO:0006538 | glutamate catabolic process | 4.212601e-3 |
GO:0071635 | negative regulation of transforming growth factor beta production | 4.215634e-3 |
GO:0006559 | L-phenylalanine catabolic process | 4.227918e-3 |
GO:0009225 | nucleotide-sugar metabolic process | 4.270053e-3 |
GO:0032765 | positive regulation of mast cell cytokine production | 4.342690e-3 |
GO:0051255 | spindle midzone assembly | 4.385613e-3 |
GO:0006383 | transcription from RNA polymerase III promoter | 4.392244e-3 |
GO:0006635 | fatty acid beta-oxidation | 4.403867e-3 |
GO:2000773 | negative regulation of cellular senescence | 4.467868e-3 |
GO:0043697 | cell dedifferentiation | 4.467868e-3 |
GO:0045627 | positive regulation of T-helper 1 cell differentiation | 4.559841e-3 |
GO:0045993 | negative regulation of translational initiation by iron | 4.765307e-3 |
GO:0046986 | negative regulation of hemoglobin biosynthetic process | 4.765307e-3 |
GO:0014738 | regulation of muscle hyperplasia | 4.769225e-3 |
GO:0006900 | membrane budding | 4.773952e-3 |
GO:0015961 | diadenosine polyphosphate catabolic process | 4.877714e-3 |
GO:0042109 | lymphotoxin A biosynthetic process | 4.877714e-3 |
GO:0006527 | arginine catabolic process | 4.903278e-3 |
GO:0006386 | termination of RNA polymerase III transcription | 4.932436e-3 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 4.932436e-3 |
GO:0006779 | porphyrin-containing compound biosynthetic process | 4.992119e-3 |
GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation | 5.009829e-3 |
GO:0000080 | G1 phase of mitotic cell cycle | 5.029279e-3 |
GO:0042073 | intraflagellar transport | 5.040508e-3 |
GO:0018283 | iron incorporation into metallo-sulfur cluster | 5.098532e-3 |
GO:0043268 | positive regulation of potassium ion transport | 5.134308e-3 |
GO:0044268 | multicellular organismal protein metabolic process | 5.141432e-3 |
GO:0090304 | nucleic acid metabolic process | 5.156297e-3 |
GO:0060430 | lung saccule development | 5.352453e-3 |
GO:0006478 | peptidyl-tyrosine sulfation | 5.357769e-3 |
GO:0031124 | mRNA 3'-end processing | 5.459160e-3 |
GO:0006760 | folic acid-containing compound metabolic process | 5.580201e-3 |
GO:0006465 | signal peptide processing | 5.594911e-3 |
GO:0061084 | negative regulation of protein refolding | 5.603231e-3 |
GO:0051935 | glutamate uptake involved in synaptic transmission | 5.700945e-3 |
GO:0006540 | glutamate decarboxylation to succinate | 5.708496e-3 |
GO:0071951 | conversion of methionyl-tRNA to N-formyl-methionyl-tRNA | 5.739279e-3 |
GO:0071557 | histone H3-K27 demethylation | 5.914911e-3 |
GO:0035574 | histone H4-K20 demethylation | 5.914911e-3 |
GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 5.952380e-3 |
GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis | 5.952380e-3 |
GO:0050951 | sensory perception of temperature stimulus | 6.057856e-3 |
GO:2000124 | regulation of endocannabinoid signaling pathway | 6.057856e-3 |
GO:0000076 | DNA replication checkpoint | 6.057856e-3 |
GO:0051549 | positive regulation of keratinocyte migration | 6.066444e-3 |
GO:0010837 | regulation of keratinocyte proliferation | 6.100472e-3 |
GO:0043128 | positive regulation of 1-phosphatidylinositol 4-kinase activity | 6.151175e-3 |
GO:0035470 | positive regulation of vascular wound healing | 6.151175e-3 |
GO:0060971 | embryonic heart tube left/right pattern formation | 6.181765e-3 |
GO:0060920 | pacemaker cell differentiation | 6.181765e-3 |
GO:0046474 | glycerophospholipid biosynthetic process | 6.213402e-3 |
GO:0006778 | porphyrin-containing compound metabolic process | 6.269180e-3 |
GO:0040040 | thermosensory behavior | 6.465616e-3 |
GO:0016574 | histone ubiquitination | 6.596760e-3 |
GO:0051256 | spindle midzone assembly involved in mitosis | 6.759011e-3 |
GO:0032912 | negative regulation of transforming growth factor beta2 production | 6.759011e-3 |
GO:0035881 | amacrine cell differentiation | 6.912200e-3 |
GO:0035583 | negative regulation of transforming growth factor beta receptor signaling pathway by extracellular sequestering of TGFbeta | 6.912352e-3 |
GO:0070159 | mitochondrial threonyl-tRNA aminoacylation | 7.042157e-3 |
GO:0070543 | response to linoleic acid | 7.042157e-3 |
GO:0034696 | response to prostaglandin F stimulus | 7.042157e-3 |
GO:0006505 | GPI anchor metabolic process | 7.106556e-3 |
GO:0061011 | hepatic duct development | 7.121945e-3 |
GO:0051083 | 'de novo' cotranslational protein folding | 7.121945e-3 |
GO:0006414 | translational elongation | 7.244459e-3 |
GO:0031860 | telomeric 3' overhang formation | 7.301090e-3 |
GO:0018931 | naphthalene metabolic process | 7.301090e-3 |
GO:0007113 | endomitotic cell cycle | 7.301090e-3 |
GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation | 7.301090e-3 |
GO:0060708 | spongiotrophoblast differentiation | 7.396484e-3 |
GO:0030260 | entry into host cell | 7.438282e-3 |
GO:0001696 | gastric acid secretion | 7.607346e-3 |
GO:0070534 | protein K63-linked ubiquitination | 7.679024e-3 |
GO:0070103 | regulation of interleukin-6-mediated signaling pathway | 7.708123e-3 |
GO:0042226 | interleukin-6 biosynthetic process | 7.721852e-3 |
GO:0071826 | ribonucleoprotein complex subunit organization | 7.867984e-3 |
GO:0022601 | menstrual cycle phase | 7.940599e-3 |
GO:0071224 | cellular response to peptidoglycan | 7.986097e-3 |
GO:0033687 | osteoblast proliferation | 8.490387e-3 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 8.559415e-3 |
GO:0051084 | 'de novo' posttranslational protein folding | 8.839915e-3 |
GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway | 8.905010e-3 |
GO:0031284 | positive regulation of guanylate cyclase activity | 8.905010e-3 |
GO:0009296 | flagellum assembly | 8.934416e-3 |
GO:0033013 | tetrapyrrole metabolic process | 9.018703e-3 |
GO:0019637 | organophosphate metabolic process | 9.164403e-3 |
GO:0032608 | interferon-beta production | 9.254211e-3 |
GO:0042312 | regulation of vasodilation | 9.375786e-3 |
GO:0014029 | neural crest formation | 9.451365e-3 |
GO:0060807 | regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification | 9.519887e-3 |
GO:0045007 | depurination | 9.519887e-3 |
GO:0003142 | cardiogenic plate morphogenesis | 9.519887e-3 |
GO:0034971 | histone H3-R17 methylation | 9.935699e-3 |
GO:0009065 | glutamine family amino acid catabolic process | 9.947375e-3 |
GO:0016048 | detection of temperature stimulus | 9.949021e-3 |
GO:0014034 | neural crest cell fate commitment | 9.949021e-3 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.010063e-2 |
GO:0060479 | lung cell differentiation | 1.035113e-2 |
GO:0032229 | negative regulation of synaptic transmission, GABAergic | 1.036451e-2 |
GO:0006119 | oxidative phosphorylation | 1.036687e-2 |
GO:0044254 | multicellular organismal protein catabolic process | 1.050897e-2 |
GO:0016559 | peroxisome fission | 1.057795e-2 |
GO:0043266 | regulation of potassium ion transport | 1.067445e-2 |
GO:0070986 | left/right axis specification | 1.079195e-2 |
GO:0016476 | regulation of embryonic cell shape | 1.079195e-2 |
GO:0032288 | myelin assembly | 1.103500e-2 |
GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus | 1.107442e-2 |
GO:0034014 | response to triglyceride | 1.121225e-2 |
GO:0034501 | protein localization to kinetochore | 1.122481e-2 |
GO:0051586 | positive regulation of dopamine uptake | 1.159721e-2 |
GO:0045454 | cell redox homeostasis | 1.176557e-2 |
GO:0019478 | D-amino acid catabolic process | 1.178805e-2 |
GO:0032241 | positive regulation of nucleobase-containing compound transport | 1.178805e-2 |
GO:0010986 | positive regulation of lipoprotein particle clearance | 1.178805e-2 |
GO:0009107 | lipoate biosynthetic process | 1.178805e-2 |
GO:0008298 | intracellular mRNA localization | 1.180329e-2 |
GO:0060712 | spongiotrophoblast layer development | 1.194928e-2 |
GO:0006901 | vesicle coating | 1.201682e-2 |
GO:0051793 | medium-chain fatty acid catabolic process | 1.205991e-2 |
GO:0070179 | D-serine biosynthetic process | 1.205991e-2 |
GO:0046629 | gamma-delta T cell activation | 1.205991e-2 |
GO:0023035 | CD40 signaling pathway | 1.205991e-2 |
GO:0010571 | positive regulation of DNA replication involved in S phase | 1.205991e-2 |
GO:0006188 | IMP biosynthetic process | 1.246604e-2 |
GO:0030573 | bile acid catabolic process | 1.246780e-2 |
GO:0046426 | negative regulation of JAK-STAT cascade | 1.249744e-2 |
GO:0048268 | clathrin coat assembly | 1.253260e-2 |
GO:0006412 | translation | 1.260596e-2 |
GO:0090224 | regulation of spindle organization | 1.261975e-2 |
GO:0046085 | adenosine metabolic process | 1.283152e-2 |
GO:0007288 | sperm axoneme assembly | 1.284588e-2 |
GO:0060271 | cilium morphogenesis | 1.300596e-2 |
GO:0008033 | tRNA processing | 1.307425e-2 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 1.319160e-2 |
GO:0002001 | renin secretion into blood stream | 1.350153e-2 |
GO:0009060 | aerobic respiration | 1.353456e-2 |
GO:0030174 | regulation of DNA-dependent DNA replication initiation | 1.358698e-2 |
GO:0006011 | UDP-glucose metabolic process | 1.358698e-2 |
GO:0071777 | positive regulation of cell cycle cytokinesis | 1.366110e-2 |
GO:0044272 | sulfur compound biosynthetic process | 1.377291e-2 |
GO:0060290 | transdifferentiation | 1.392811e-2 |
GO:0006346 | methylation-dependent chromatin silencing | 1.392811e-2 |
GO:0046502 | uroporphyrinogen III metabolic process | 1.397433e-2 |
GO:0006620 | posttranslational protein targeting to membrane | 1.414282e-2 |
GO:0090230 | regulation of centromere complex assembly | 1.429463e-2 |
GO:0043984 | histone H4-K16 acetylation | 1.429463e-2 |
GO:0033091 | positive regulation of immature T cell proliferation | 1.430815e-2 |
GO:0046952 | ketone body catabolic process | 1.432281e-2 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 1.432281e-2 |
GO:0006104 | succinyl-CoA metabolic process | 1.432281e-2 |
GO:0071843 | cellular component biogenesis at cellular level | 1.432787e-2 |
GO:0033522 | histone H2A ubiquitination | 1.448164e-2 |
GO:0019673 | GDP-mannose metabolic process | 1.457206e-2 |
GO:0001881 | receptor recycling | 1.458882e-2 |
GO:0019509 | L-methionine salvage from methylthioadenosine | 1.461517e-2 |
GO:0008654 | phospholipid biosynthetic process | 1.468285e-2 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.475195e-2 |
GO:0006506 | GPI anchor biosynthetic process | 1.516026e-2 |
GO:0019395 | fatty acid oxidation | 1.532456e-2 |
GO:0015867 | ATP transport | 1.535465e-2 |
GO:0042255 | ribosome assembly | 1.558956e-2 |
GO:0021523 | somatic motor neuron differentiation | 1.564022e-2 |
GO:0043931 | ossification involved in bone maturation | 1.579810e-2 |
GO:0009451 | RNA modification | 1.603760e-2 |
GO:0016180 | snRNA processing | 1.633773e-2 |
GO:0032439 | endosome localization | 1.634833e-2 |
GO:0000237 | leptotene | 1.634833e-2 |
GO:0000715 | nucleotide-excision repair, DNA damage recognition | 1.637264e-2 |
GO:0035269 | protein O-linked mannosylation | 1.667075e-2 |
GO:0003222 | ventricular trabecular myocardium morphogenesis | 1.667075e-2 |
GO:0033153 | T cell receptor V(D)J recombination | 1.676179e-2 |
GO:0034421 | post-translational protein acetylation | 1.695479e-2 |
GO:0019254 | carnitine metabolic process, CoA-linked | 1.695479e-2 |
GO:0010735 | positive regulation of transcription via serum response element binding | 1.695479e-2 |
GO:0018344 | protein geranylgeranylation | 1.695479e-2 |
GO:0021932 | hindbrain radial glia guided cell migration | 1.765648e-2 |
GO:0018202 | peptidyl-histidine modification | 1.765648e-2 |
GO:0060674 | placenta blood vessel development | 1.782375e-2 |
GO:0002017 | regulation of blood volume by renal aldosterone | 1.818169e-2 |
GO:0006393 | termination of mitochondrial transcription | 1.821760e-2 |
GO:0034440 | lipid oxidation | 1.822556e-2 |
GO:0006544 | glycine metabolic process | 1.855543e-2 |
GO:0010950 | positive regulation of endopeptidase activity | 1.873165e-2 |
GO:0030223 | neutrophil differentiation | 1.873165e-2 |
GO:0000730 | DNA recombinase assembly | 1.873165e-2 |
GO:0043064 | flagellum organization | 1.882066e-2 |
GO:0032007 | negative regulation of TOR signaling cascade | 1.882066e-2 |
GO:0021952 | central nervous system projection neuron axonogenesis | 1.886998e-2 |
GO:0009437 | carnitine metabolic process | 1.926233e-2 |
GO:0048861 | leukemia inhibitory factor signaling pathway | 1.931508e-2 |
GO:0042637 | catagen | 1.938740e-2 |
GO:0051299 | centrosome separation | 1.957893e-2 |
GO:0033034 | positive regulation of myeloid cell apoptosis | 1.957893e-2 |
GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity | 1.963640e-2 |
GO:0016482 | cytoplasmic transport | 1.970473e-2 |
GO:0090075 | relaxation of muscle | 2.034529e-2 |
GO:0010288 | response to lead ion | 2.053163e-2 |
GO:0021943 | formation of radial glial scaffolds | 2.130347e-2 |
GO:0051168 | nuclear export | 2.130888e-2 |
GO:0032239 | regulation of nucleobase-containing compound transport | 2.166797e-2 |
GO:0035412 | regulation of catenin import into nucleus | 2.167323e-2 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 2.182559e-2 |
GO:0007412 | axon target recognition | 2.182559e-2 |
GO:0045908 | negative regulation of vasodilation | 2.209462e-2 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.225990e-2 |
GO:0050651 | dermatan sulfate proteoglycan biosynthetic process | 2.233693e-2 |
GO:0034059 | response to anoxia | 2.233693e-2 |
GO:0015822 | ornithine transport | 2.247375e-2 |
GO:0051531 | NFAT protein import into nucleus | 2.247375e-2 |
GO:0042053 | regulation of dopamine metabolic process | 2.274892e-2 |
GO:0033131 | regulation of glucokinase activity | 2.310159e-2 |
GO:0019062 | virion attachment to host cell surface receptor | 2.310159e-2 |
GO:0043503 | skeletal muscle fiber adaptation | 2.322758e-2 |
GO:0007031 | peroxisome organization | 2.323919e-2 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 2.334886e-2 |
GO:2000300 | regulation of synaptic vesicle exocytosis | 2.361769e-2 |
GO:0060659 | nipple sheath formation | 2.377999e-2 |
GO:0060649 | mammary gland bud elongation | 2.377999e-2 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 2.383886e-2 |
GO:0070106 | interleukin-27-mediated signaling pathway | 2.387615e-2 |
GO:0045653 | negative regulation of megakaryocyte differentiation | 2.387615e-2 |
GO:0015868 | purine ribonucleotide transport | 2.387615e-2 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 2.411208e-2 |
GO:0048103 | somatic stem cell division | 2.418579e-2 |
GO:0035306 | positive regulation of dephosphorylation | 2.430345e-2 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 2.441723e-2 |
GO:0045739 | positive regulation of DNA repair | 2.476662e-2 |
GO:0071895 | odontoblast differentiation | 2.541605e-2 |
GO:0055099 | response to high density lipoprotein particle stimulus | 2.541605e-2 |
GO:0019532 | oxalate transport | 2.541605e-2 |
GO:0009069 | serine family amino acid metabolic process | 2.545549e-2 |
GO:0048002 | antigen processing and presentation of peptide antigen | 2.571680e-2 |
GO:0016095 | polyprenol catabolic process | 2.580596e-2 |
GO:0060209 | estrus | 2.580596e-2 |
GO:0097037 | heme export | 2.580596e-2 |
GO:0033262 | regulation of DNA replication involved in S phase | 2.580596e-2 |
GO:0006893 | Golgi to plasma membrane transport | 2.592363e-2 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.650836e-2 |
GO:0003285 | septum secundum development | 2.669954e-2 |
GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway | 2.685122e-2 |
GO:0010034 | response to acetate | 2.685122e-2 |
GO:0061017 | hepatoblast differentiation | 2.685122e-2 |
GO:0001561 | fatty acid alpha-oxidation | 2.703151e-2 |
GO:0009311 | oligosaccharide metabolic process | 2.740843e-2 |
GO:0032467 | positive regulation of cytokinesis | 2.773424e-2 |
GO:0006285 | base-excision repair, AP site formation | 2.774998e-2 |
GO:0042711 | maternal behavior | 2.774998e-2 |
GO:0017085 | response to insecticide | 2.790036e-2 |
GO:0042069 | regulation of catecholamine metabolic process | 2.820600e-2 |
GO:0002016 | regulation of blood volume by renin-angiotensin | 2.860774e-2 |
GO:2000016 | negative regulation of determination of dorsal identity | 2.864863e-2 |
GO:0050655 | dermatan sulfate proteoglycan metabolic process | 2.866910e-2 |
GO:0007260 | tyrosine phosphorylation of STAT protein | 2.872244e-2 |
GO:0032637 | interleukin-8 production | 2.912152e-2 |
GO:0090307 | spindle assembly involved in mitosis | 2.934885e-2 |
GO:0035330 | regulation of hippo signaling cascade | 2.934885e-2 |
GO:0032446 | protein modification by small protein conjugation | 2.951664e-2 |
GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process | 2.965412e-2 |
GO:0045046 | protein import into peroxisome membrane | 2.965412e-2 |
GO:0009650 | UV protection | 2.981673e-2 |
GO:0033602 | negative regulation of dopamine secretion | 2.985867e-2 |
GO:0014002 | astrocyte development | 2.998168e-2 |
GO:0051488 | activation of anaphase-promoting complex activity | 3.023399e-2 |
GO:0035284 | brain segmentation | 3.023399e-2 |
GO:0007097 | nuclear migration | 3.069981e-2 |
GO:2000481 | positive regulation of cAMP-dependent protein kinase activity | 3.099265e-2 |
GO:2000534 | positive regulation of renal albumin absorption | 3.099265e-2 |
GO:0070845 | polyubiquitinated misfolded protein transport | 3.099265e-2 |
GO:2000478 | positive regulation of metanephric glomerular visceral epithelial cell development | 3.099265e-2 |
GO:2000461 | negative regulation of eukaryotic cell surface binding | 3.099265e-2 |
GO:0070994 | detection of oxidative stress | 3.099265e-2 |
GO:0060266 | negative regulation of respiratory burst involved in inflammatory response | 3.104252e-2 |
GO:0034470 | ncRNA processing | 3.105300e-2 |
GO:0018146 | keratan sulfate biosynthetic process | 3.105644e-2 |
GO:0070262 | peptidyl-serine dephosphorylation | 3.105644e-2 |
GO:0035307 | positive regulation of protein dephosphorylation | 3.123818e-2 |
GO:0001977 | renal system process involved in regulation of blood volume | 3.142959e-2 |
GO:0035721 | intraflagellar retrograde transport | 3.146039e-2 |
GO:0007206 | activation of phospholipase C activity by metabotropic glutamate receptor signaling pathway | 3.146039e-2 |
GO:0002005 | angiotensin catabolic process in blood | 3.146039e-2 |
GO:0006401 | RNA catabolic process | 3.170415e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0042268 | regulation of cytolysis | 3.230096e-10 |
GO:0006396 | RNA processing | 3.546372e-8 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 8.805467e-8 |
GO:0032200 | telomere organization | 1.092996e-7 |
GO:0030262 | apoptotic nuclear change | 1.421639e-7 |
GO:0000080 | G1 phase of mitotic cell cycle | 1.905590e-7 |
GO:0030263 | apoptotic chromosome condensation | 2.471705e-7 |
GO:0008535 | respiratory chain complex IV assembly | 2.992255e-7 |
GO:0045292 | nuclear mRNA cis splicing, via spliceosome | 3.644521e-7 |
GO:0032202 | telomere assembly | 8.073606e-7 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 8.270395e-7 |
GO:0010897 | negative regulation of triglyceride catabolic process | 8.270395e-7 |
GO:0010833 | telomere maintenance via telomere lengthening | 8.270395e-7 |
GO:0051661 | maintenance of centrosome location | 9.497356e-7 |
GO:0006921 | cellular component disassembly involved in apoptosis | 1.129852e-6 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.362110e-6 |
GO:0006259 | DNA metabolic process | 1.513150e-6 |
GO:0006409 | tRNA export from nucleus | 2.364156e-6 |
GO:0045919 | positive regulation of cytolysis | 2.932400e-6 |
GO:0001843 | neural tube closure | 3.805989e-6 |
GO:0071103 | DNA conformation change | 3.993005e-6 |
GO:0032781 | positive regulation of ATPase activity | 4.192210e-6 |
GO:0048239 | negative regulation of DNA recombination at telomere | 4.309749e-6 |
GO:0006430 | lysyl-tRNA aminoacylation | 4.309749e-6 |
GO:0044260 | cellular macromolecule metabolic process | 4.649259e-6 |
GO:0060621 | negative regulation of cholesterol import | 5.817651e-6 |
GO:0000422 | mitochondrion degradation | 5.937728e-6 |
GO:0070979 | protein K11-linked ubiquitination | 7.527322e-6 |
GO:0051318 | G1 phase | 7.849997e-6 |
GO:0006261 | DNA-dependent DNA replication | 8.574537e-6 |
GO:0018293 | protein-FAD linkage | 8.773007e-6 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 8.773007e-6 |
GO:0060606 | tube closure | 1.008110e-5 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 1.098907e-5 |
GO:0045918 | negative regulation of cytolysis | 1.194382e-5 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 1.217481e-5 |
GO:0008380 | RNA splicing | 1.268434e-5 |
GO:0000723 | telomere maintenance | 1.420368e-5 |
GO:0006493 | protein O-linked glycosylation | 1.593705e-5 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 1.661061e-5 |
GO:0016071 | mRNA metabolic process | 1.671145e-5 |
GO:0060620 | regulation of cholesterol import | 1.722738e-5 |
GO:0000395 | nuclear mRNA 5'-splice site recognition | 1.839405e-5 |
GO:0000432 | positive regulation of transcription from RNA polymerase II promoter by glucose | 2.388896e-5 |
GO:0022411 | cellular component disassembly | 2.595021e-5 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 3.040141e-5 |
GO:0035799 | ureter maturation | 3.138323e-5 |
GO:2000597 | positive regulation of optic nerve formation | 3.138323e-5 |
GO:0061360 | optic chiasma development | 3.138323e-5 |
GO:0021650 | vestibulocochlear nerve formation | 3.138323e-5 |
GO:0021633 | optic nerve structural organization | 3.138323e-5 |
GO:0071845 | cellular component disassembly at cellular level | 3.151159e-5 |
GO:0051168 | nuclear export | 3.301478e-5 |
GO:0042661 | regulation of mesodermal cell fate specification | 3.377637e-5 |
GO:0050713 | negative regulation of interleukin-1 beta secretion | 3.674767e-5 |
GO:0048378 | regulation of lateral mesodermal cell fate specification | 3.759862e-5 |
GO:0050821 | protein stabilization | 3.990122e-5 |
GO:0003350 | pulmonary myocardium development | 4.196679e-5 |
GO:0000189 | MAPK import into nucleus | 5.228933e-5 |
GO:0010994 | free ubiquitin chain polymerization | 5.228933e-5 |
GO:0090304 | nucleic acid metabolic process | 5.331666e-5 |
GO:0050711 | negative regulation of interleukin-1 secretion | 5.652502e-5 |
GO:0031848 | protection from non-homologous end joining at telomere | 5.967389e-5 |
GO:0048352 | paraxial mesoderm structural organization | 6.180309e-5 |
GO:0021998 | neural plate mediolateral regionalization | 6.180309e-5 |
GO:0032203 | telomere formation via telomerase | 6.180309e-5 |
GO:0006268 | DNA unwinding involved in replication | 6.374626e-5 |
GO:0032872 | regulation of stress-activated MAPK cascade | 6.439877e-5 |
GO:0006397 | mRNA processing | 6.537798e-5 |
GO:0033235 | positive regulation of protein sumoylation | 7.031165e-5 |
GO:0014020 | primary neural tube formation | 7.424806e-5 |
GO:0031536 | positive regulation of exit from mitosis | 7.745289e-5 |
GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | 7.796162e-5 |
GO:0015966 | diadenosine tetraphosphate biosynthetic process | 7.822259e-5 |
GO:2000380 | regulation of mesoderm development | 8.566635e-5 |
GO:0051973 | positive regulation of telomerase activity | 8.831193e-5 |
GO:0042559 | pteridine-containing compound biosynthetic process | 9.199051e-5 |
GO:0006290 | pyrimidine dimer repair | 1.000476e-4 |
GO:0032218 | riboflavin transport | 1.156662e-4 |
GO:0046654 | tetrahydrofolate biosynthetic process | 1.276407e-4 |
GO:0060266 | negative regulation of respiratory burst involved in inflammatory response | 1.290115e-4 |
GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity | 1.805922e-4 |
GO:0072355 | histone H3-T3 phosphorylation | 1.939719e-4 |
GO:0051891 | positive regulation of cardioblast differentiation | 1.959530e-4 |
GO:0006308 | DNA catabolic process | 2.130872e-4 |
GO:0006323 | DNA packaging | 2.134307e-4 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 2.147217e-4 |
GO:0022417 | protein maturation by protein folding | 2.147217e-4 |
GO:0007492 | endoderm development | 2.197550e-4 |
GO:0051684 | maintenance of Golgi location | 2.378036e-4 |
GO:0070165 | positive regulation of adiponectin secretion | 2.378036e-4 |
GO:0033617 | mitochondrial respiratory chain complex IV assembly | 2.378036e-4 |
GO:0033031 | positive regulation of neutrophil apoptosis | 2.378036e-4 |
GO:0046452 | dihydrofolate metabolic process | 2.378036e-4 |
GO:0072003 | kidney rudiment formation | 2.506174e-4 |
GO:0019348 | dolichol metabolic process | 2.506174e-4 |
GO:0032205 | negative regulation of telomere maintenance | 2.677094e-4 |
GO:0042696 | menarche | 2.775110e-4 |
GO:0035269 | protein O-linked mannosylation | 2.788677e-4 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 2.806907e-4 |
GO:0090209 | negative regulation of triglyceride metabolic process | 3.103868e-4 |
GO:0072221 | metanephric distal convoluted tubule development | 3.234765e-4 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 3.304388e-4 |
GO:0007501 | mesodermal cell fate specification | 3.322929e-4 |
GO:0048340 | paraxial mesoderm morphogenesis | 3.460771e-4 |
GO:0006139 | nucleobase-containing compound metabolic process | 3.552254e-4 |
GO:0046653 | tetrahydrofolate metabolic process | 3.596875e-4 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 3.596875e-4 |
GO:0045175 | basal protein localization | 3.701858e-4 |
GO:0044237 | cellular metabolic process | 3.750731e-4 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 3.765251e-4 |
GO:0006403 | RNA localization | 3.771972e-4 |
GO:0019359 | nicotinamide nucleotide biosynthetic process | 3.901182e-4 |
GO:0006974 | response to DNA damage stimulus | 3.946184e-4 |
GO:0003406 | retinal pigment epithelium development | 3.987054e-4 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 4.059123e-4 |
GO:0034660 | ncRNA metabolic process | 4.077618e-4 |
GO:0031647 | regulation of protein stability | 4.100671e-4 |
GO:0006264 | mitochondrial DNA replication | 4.149074e-4 |
GO:0000278 | mitotic cell cycle | 4.183595e-4 |
GO:0032508 | DNA duplex unwinding | 4.391894e-4 |
GO:0070286 | axonemal dynein complex assembly | 4.584948e-4 |
GO:0021759 | globus pallidus development | 4.705737e-4 |
GO:0048285 | organelle fission | 4.867015e-4 |
GO:0034470 | ncRNA processing | 5.090269e-4 |
GO:0000375 | RNA splicing, via transesterification reactions | 5.822971e-4 |
GO:0032392 | DNA geometric change | 5.888058e-4 |
GO:0046103 | inosine biosynthetic process | 6.014729e-4 |
GO:0016191 | synaptic vesicle uncoating | 6.014729e-4 |
GO:0006154 | adenosine catabolic process | 6.014729e-4 |
GO:0034380 | high-density lipoprotein particle assembly | 6.024832e-4 |
GO:0042335 | cuticle development | 6.036606e-4 |
GO:0007004 | telomere maintenance via telomerase | 6.210630e-4 |
GO:0051169 | nuclear transport | 6.428878e-4 |
GO:0035481 | positive regulation of Notch signaling pathway involved in heart induction | 6.653348e-4 |
GO:0060975 | cardioblast migration to the midline involved in heart field formation | 6.653348e-4 |
GO:0003210 | cardiac atrium formation | 6.653348e-4 |
GO:0009159 | deoxyribonucleoside monophosphate catabolic process | 6.653348e-4 |
GO:0003259 | cardioblast anterior-lateral migration | 6.653348e-4 |
GO:0003236 | sinus venosus morphogenesis | 6.653348e-4 |
GO:0021877 | forebrain neuron fate commitment | 6.814180e-4 |
GO:0050658 | RNA transport | 6.880290e-4 |
GO:0022403 | cell cycle phase | 7.370865e-4 |
GO:0045347 | negative regulation of MHC class II biosynthetic process | 7.544957e-4 |
GO:0030719 | P granule organization | 7.544957e-4 |
GO:0070194 | synaptonemal complex disassembly | 7.551744e-4 |
GO:0035674 | tricarboxylic acid transmembrane transport | 7.551744e-4 |
GO:0007183 | SMAD protein complex assembly | 7.573193e-4 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 7.598637e-4 |
GO:0007131 | reciprocal meiotic recombination | 7.700573e-4 |
GO:0046474 | glycerophospholipid biosynthetic process | 7.857391e-4 |
GO:0051188 | cofactor biosynthetic process | 7.866072e-4 |
GO:0006913 | nucleocytoplasmic transport | 8.352505e-4 |
GO:2000971 | negative regulation of detection of glucose | 8.860138e-4 |
GO:0006545 | glycine biosynthetic process | 8.860138e-4 |
GO:2000976 | regulation of transcription from RNA polymerase II promoter involved in detection of glucose | 8.860138e-4 |
GO:0006189 | 'de novo' IMP biosynthetic process | 8.860138e-4 |
GO:0000433 | negative regulation of transcription from RNA polymerase II promoter by glucose | 8.860138e-4 |
GO:0048339 | paraxial mesoderm development | 8.967281e-4 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 9.180154e-4 |
GO:0000819 | sister chromatid segregation | 9.604638e-4 |
GO:0072177 | mesonephric duct development | 9.632220e-4 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 9.739874e-4 |
GO:0006412 | translation | 9.819052e-4 |
GO:0072305 | negative regulation of mesenchymal stem cell apoptosis involved in metanephric nephron morphogenesis | 1.009564e-3 |
GO:2000594 | positive regulation of metanephric DCT cell differentiation | 1.009564e-3 |
GO:0039003 | pronephric field specification | 1.009564e-3 |
GO:0006383 | transcription from RNA polymerase III promoter | 1.017895e-3 |
GO:0043045 | DNA methylation involved in embryo development | 1.017895e-3 |
GO:0006269 | DNA replication, synthesis of RNA primer | 1.017895e-3 |
GO:0006405 | RNA export from nucleus | 1.043264e-3 |
GO:0010896 | regulation of triglyceride catabolic process | 1.075595e-3 |
GO:0008637 | apoptotic mitochondrial changes | 1.083126e-3 |
GO:0051450 | myoblast proliferation | 1.084586e-3 |
GO:0048368 | lateral mesoderm development | 1.102629e-3 |
GO:0006281 | DNA repair | 1.141342e-3 |
GO:0070198 | protein localization to chromosome, telomeric region | 1.192302e-3 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 1.202282e-3 |
GO:0051586 | positive regulation of dopamine uptake | 1.232540e-3 |
GO:0048382 | mesendoderm development | 1.232540e-3 |
GO:0072171 | mesonephric tubule morphogenesis | 1.269372e-3 |
GO:0016068 | type I hypersensitivity | 1.288098e-3 |
GO:0061017 | hepatoblast differentiation | 1.295539e-3 |
GO:0019049 | evasion of host defenses by virus | 1.295539e-3 |
GO:0021562 | vestibulocochlear nerve development | 1.329120e-3 |
GO:0007412 | axon target recognition | 1.329120e-3 |
GO:0006784 | heme a biosynthetic process | 1.329120e-3 |
GO:0033233 | regulation of protein sumoylation | 1.369141e-3 |
GO:0046102 | inosine metabolic process | 1.383196e-3 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.393626e-3 |
GO:0009786 | regulation of asymmetric cell division | 1.448151e-3 |
GO:0021915 | neural tube development | 1.563386e-3 |
GO:0019438 | aromatic compound biosynthetic process | 1.586692e-3 |
GO:0032914 | positive regulation of transforming growth factor beta1 production | 1.631073e-3 |
GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly | 1.631073e-3 |
GO:0002098 | tRNA wobble uridine modification | 1.631073e-3 |
GO:2000078 | positive regulation of type B pancreatic cell development | 1.676695e-3 |
GO:0042747 | circadian sleep/wake cycle, REM sleep | 1.676695e-3 |
GO:0032289 | central nervous system myelin formation | 1.676695e-3 |
GO:0009435 | NAD biosynthetic process | 1.689185e-3 |
GO:0070534 | protein K63-linked ubiquitination | 1.717583e-3 |
GO:0035566 | regulation of metanephros size | 1.724080e-3 |
GO:0007067 | mitosis | 1.756350e-3 |
GO:0046785 | microtubule polymerization | 1.799289e-3 |
GO:0042773 | ATP synthesis coupled electron transport | 1.804776e-3 |
GO:0021797 | forebrain anterior/posterior pattern specification | 1.879809e-3 |
GO:0032874 | positive regulation of stress-activated MAPK cascade | 1.879809e-3 |
GO:0043488 | regulation of mRNA stability | 1.899508e-3 |
GO:0071636 | positive regulation of transforming growth factor beta production | 1.920799e-3 |
GO:0060795 | cell fate commitment involved in formation of primary germ layers | 1.938312e-3 |
GO:0030300 | regulation of intestinal cholesterol absorption | 1.975491e-3 |
GO:0000279 | M phase | 1.995825e-3 |
GO:0009108 | coenzyme biosynthetic process | 2.015046e-3 |
GO:0044340 | canonical Wnt receptor signaling pathway involved in regulation of cell proliferation | 2.032784e-3 |
GO:0046499 | S-adenosylmethioninamine metabolic process | 2.032784e-3 |
GO:0018158 | protein oxidation | 2.054795e-3 |
GO:0061011 | hepatic duct development | 2.054795e-3 |
GO:0010825 | positive regulation of centrosome duplication | 2.054795e-3 |
GO:0006713 | glucocorticoid catabolic process | 2.054795e-3 |
GO:0000722 | telomere maintenance via recombination | 2.054795e-3 |
GO:0071173 | spindle assembly checkpoint | 2.078100e-3 |
GO:0042558 | pteridine-containing compound metabolic process | 2.092340e-3 |
GO:0034227 | tRNA thio-modification | 2.206208e-3 |
GO:0008078 | mesodermal cell migration | 2.220348e-3 |
GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane | 2.235815e-3 |
GO:0090074 | negative regulation of protein homodimerization activity | 2.235815e-3 |
GO:0016559 | peroxisome fission | 2.235815e-3 |
GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c | 2.235815e-3 |
GO:0045769 | negative regulation of asymmetric cell division | 2.261617e-3 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 2.261617e-3 |
GO:0007549 | dosage compensation | 2.409898e-3 |
GO:0007265 | Ras protein signal transduction | 2.448918e-3 |
GO:0000087 | M phase of mitotic cell cycle | 2.454278e-3 |
GO:0007096 | regulation of exit from mitosis | 2.546585e-3 |
GO:0048793 | pronephros development | 2.570717e-3 |
GO:0034377 | plasma lipoprotein particle assembly | 2.601777e-3 |
GO:0051890 | regulation of cardioblast differentiation | 2.679199e-3 |
GO:0048854 | brain morphogenesis | 2.692734e-3 |
GO:0060928 | atrioventricular node cell development | 2.702330e-3 |
GO:0019858 | cytosine metabolic process | 2.702330e-3 |
GO:0060929 | atrioventricular node cell fate commitment | 2.702330e-3 |
GO:0003168 | cardiac Purkinje fiber cell differentiation | 2.702330e-3 |
GO:0003342 | proepicardium development | 2.702330e-3 |
GO:0030950 | establishment or maintenance of actin cytoskeleton polarity | 2.766808e-3 |
GO:0010608 | posttranscriptional regulation of gene expression | 2.776061e-3 |
GO:0072172 | mesonephric tubule formation | 2.782029e-3 |
GO:0014051 | gamma-aminobutyric acid secretion | 2.782029e-3 |
GO:0071459 | protein localization to chromosome, centromeric region | 2.788053e-3 |
GO:0060192 | negative regulation of lipase activity | 2.878727e-3 |
GO:0006561 | proline biosynthetic process | 2.928367e-3 |
GO:0051594 | detection of glucose | 2.928367e-3 |
GO:0003349 | epicardium-derived cardiac endothelial cell differentiation | 2.928367e-3 |
GO:0043949 | regulation of cAMP-mediated signaling | 2.937425e-3 |
GO:0007346 | regulation of mitotic cell cycle | 2.974226e-3 |
GO:0034622 | cellular macromolecular complex assembly | 2.994607e-3 |
GO:0022402 | cell cycle process | 3.016909e-3 |
GO:0048255 | mRNA stabilization | 3.057280e-3 |
GO:0042473 | outer ear morphogenesis | 3.058606e-3 |
GO:0000002 | mitochondrial genome maintenance | 3.058606e-3 |
GO:0034314 | Arp2/3 complex-mediated actin nucleation | 3.107676e-3 |
GO:0016266 | O-glycan processing | 3.107676e-3 |
GO:0010388 | cullin deneddylation | 3.154453e-3 |
GO:0007049 | cell cycle | 3.332452e-3 |
GO:0010984 | regulation of lipoprotein particle clearance | 3.337116e-3 |
GO:0032908 | regulation of transforming growth factor beta1 production | 3.402659e-3 |
GO:0000070 | mitotic sister chromatid segregation | 3.434015e-3 |
GO:0046015 | regulation of transcription by glucose | 3.443697e-3 |
GO:0043487 | regulation of RNA stability | 3.457778e-3 |
GO:0042775 | mitochondrial ATP synthesis coupled electron transport | 3.669388e-3 |
GO:0006260 | DNA replication | 3.688115e-3 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 3.701118e-3 |
GO:0007127 | meiosis I | 3.703448e-3 |
GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport | 3.757152e-3 |
GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine | 3.757152e-3 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 3.757152e-3 |
GO:0001705 | ectoderm formation | 3.773762e-3 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 3.790728e-3 |
GO:0072017 | distal tubule development | 3.795113e-3 |
GO:0032488 | Cdc42 protein signal transduction | 3.852698e-3 |
GO:0007028 | cytoplasm organization | 3.979246e-3 |
GO:0051235 | maintenance of location | 4.096341e-3 |
GO:0001710 | mesodermal cell fate commitment | 4.166219e-3 |
GO:0045910 | negative regulation of DNA recombination | 4.214475e-3 |
GO:0007076 | mitotic chromosome condensation | 4.214516e-3 |
GO:0043543 | protein acylation | 4.241303e-3 |
GO:0090207 | regulation of triglyceride metabolic process | 4.242389e-3 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 4.249132e-3 |
GO:0035282 | segmentation | 4.279076e-3 |
GO:0070508 | cholesterol import | 4.302050e-3 |
GO:0060264 | regulation of respiratory burst involved in inflammatory response | 4.304530e-3 |
GO:0007256 | activation of JNKK activity | 4.330735e-3 |
GO:0043666 | regulation of phosphoprotein phosphatase activity | 4.371684e-3 |
GO:0006807 | nitrogen compound metabolic process | 4.382339e-3 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 4.473849e-3 |
GO:0032472 | Golgi calcium ion transport | 4.500011e-3 |
GO:0032468 | Golgi calcium ion homeostasis | 4.500011e-3 |
GO:0008208 | C21-steroid hormone catabolic process | 4.500011e-3 |
GO:0030026 | cellular manganese ion homeostasis | 4.500011e-3 |
GO:0070163 | regulation of adiponectin secretion | 4.539464e-3 |
GO:0009798 | axis specification | 4.555962e-3 |
GO:0010467 | gene expression | 4.654401e-3 |
GO:0021871 | forebrain regionalization | 4.747068e-3 |
GO:0031577 | spindle checkpoint | 4.773022e-3 |
GO:0033132 | negative regulation of glucokinase activity | 4.792150e-3 |
GO:0043687 | post-translational protein modification | 4.855934e-3 |
GO:0021798 | forebrain dorsal/ventral pattern formation | 4.855934e-3 |
GO:0048012 | hepatocyte growth factor receptor signaling pathway | 4.857000e-3 |
GO:0006302 | double-strand break repair | 4.926992e-3 |
GO:0045945 | positive regulation of transcription from RNA polymerase III promoter | 4.935856e-3 |
GO:0018065 | protein-cofactor linkage | 4.987639e-3 |
GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 5.012406e-3 |
GO:0043491 | protein kinase B signaling cascade | 5.080781e-3 |
GO:0019673 | GDP-mannose metabolic process | 5.267408e-3 |
GO:0017004 | cytochrome complex assembly | 5.267408e-3 |
GO:0046079 | dUMP catabolic process | 5.297337e-3 |
GO:0017126 | nucleologenesis | 5.297337e-3 |
GO:0051004 | regulation of lipoprotein lipase activity | 5.497837e-3 |
GO:0072070 | loop of Henle development | 5.624536e-3 |
GO:0001836 | release of cytochrome c from mitochondria | 5.678201e-3 |
GO:0042538 | hyperosmotic salinity response | 5.707466e-3 |
GO:0016567 | protein ubiquitination | 5.808704e-3 |
GO:0045185 | maintenance of protein location | 6.010942e-3 |
GO:0016072 | rRNA metabolic process | 6.065241e-3 |
GO:0050774 | negative regulation of dendrite morphogenesis | 6.101687e-3 |
GO:0032486 | Rap protein signal transduction | 6.101687e-3 |
GO:0006777 | Mo-molybdopterin cofactor biosynthetic process | 6.128463e-3 |
GO:0021670 | lateral ventricle development | 6.139871e-3 |
GO:0006611 | protein export from nucleus | 6.275103e-3 |
GO:0015746 | citrate transport | 6.284588e-3 |
GO:0034421 | post-translational protein acetylation | 6.284588e-3 |
GO:0009817 | defense response to fungus, incompatible interaction | 6.284588e-3 |
GO:0008216 | spermidine metabolic process | 6.284588e-3 |
GO:0070193 | synaptonemal complex organization | 6.303839e-3 |
GO:0072078 | nephron tubule morphogenesis | 6.332404e-3 |
GO:0003002 | regionalization | 6.335965e-3 |
GO:0030261 | chromosome condensation | 6.540852e-3 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 6.570885e-3 |
GO:0007509 | mesoderm migration involved in gastrulation | 6.570885e-3 |
GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling | 6.637489e-3 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 6.747996e-3 |
GO:0009396 | folic acid-containing compound biosynthetic process | 6.824514e-3 |
GO:0007141 | male meiosis I | 6.875846e-3 |
GO:0060430 | lung saccule development | 6.888398e-3 |
GO:0070368 | positive regulation of hepatocyte differentiation | 7.062324e-3 |
GO:0042664 | negative regulation of endodermal cell fate specification | 7.062324e-3 |
GO:0021764 | amygdala development | 7.062324e-3 |
GO:0030878 | thyroid gland development | 7.077964e-3 |
GO:0042796 | snRNA transcription from RNA polymerase III promoter | 7.143358e-3 |
GO:0042795 | snRNA transcription from RNA polymerase II promoter | 7.143358e-3 |
GO:0035871 | protein K11-linked deubiquitination | 7.143358e-3 |
GO:0051329 | interphase of mitotic cell cycle | 7.156389e-3 |
GO:0021591 | ventricular system development | 7.247397e-3 |
GO:0016311 | dephosphorylation | 7.326174e-3 |
GO:0051325 | interphase | 7.359875e-3 |
GO:0032446 | protein modification by small protein conjugation | 7.371449e-3 |
GO:0097039 | protein linear polyubiquitination | 7.430921e-3 |
GO:0032811 | negative regulation of epinephrine secretion | 7.430921e-3 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 7.430921e-3 |
GO:2000300 | regulation of synaptic vesicle exocytosis | 7.503747e-3 |
GO:0060177 | regulation of angiotensin metabolic process | 7.503747e-3 |
GO:0071922 | regulation of cohesin localization to chromatin | 7.503747e-3 |
GO:0090009 | primitive streak formation | 7.516221e-3 |
GO:0006473 | protein acetylation | 7.611804e-3 |
GO:0006560 | proline metabolic process | 7.676205e-3 |
GO:0050768 | negative regulation of neurogenesis | 7.738810e-3 |
GO:0045922 | negative regulation of fatty acid metabolic process | 7.896568e-3 |
GO:0006470 | protein dephosphorylation | 7.911080e-3 |
GO:0051651 | maintenance of location in cell | 7.915543e-3 |
GO:0006334 | nucleosome assembly | 7.934340e-3 |
GO:0060044 | negative regulation of cardiac muscle cell proliferation | 7.957828e-3 |
GO:0072202 | cell differentiation involved in metanephros development | 7.997590e-3 |
GO:0002719 | negative regulation of cytokine production involved in immune response | 7.997590e-3 |
GO:0065005 | protein-lipid complex assembly | 8.090819e-3 |
GO:0031023 | microtubule organizing center organization | 8.131929e-3 |
GO:0051488 | activation of anaphase-promoting complex activity | 8.213058e-3 |
GO:0050995 | negative regulation of lipid catabolic process | 8.332421e-3 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 8.512494e-3 |
GO:0015959 | diadenosine polyphosphate metabolic process | 8.512494e-3 |
GO:0035695 | mitochondrion degradation by induced vacuole formation | 8.512494e-3 |
GO:0008631 | induction of apoptosis by oxidative stress | 8.557823e-3 |
GO:0040029 | regulation of gene expression, epigenetic | 8.594534e-3 |
GO:0061205 | paramesonephric duct development | 8.792744e-3 |
GO:0001841 | neural tube formation | 8.889551e-3 |
GO:0006244 | pyrimidine nucleotide catabolic process | 9.093330e-3 |
GO:0072040 | negative regulation of mesenchymal stem cell apoptosis involved in nephron morphogenesis | 9.152396e-3 |
GO:0033127 | regulation of histone phosphorylation | 9.152396e-3 |
GO:0050883 | musculoskeletal movement, spinal reflex action | 9.152396e-3 |
GO:0000209 | protein polyubiquitination | 9.342068e-3 |
GO:0045017 | glycerolipid biosynthetic process | 9.411666e-3 |
GO:0022011 | myelination in peripheral nervous system | 9.481794e-3 |
GO:0051301 | cell division | 9.795292e-3 |
GO:0042278 | purine nucleoside metabolic process | 9.923107e-3 |
GO:2000682 | positive regulation of rubidium ion transport | 9.929339e-3 |
GO:2000688 | positive regulation of rubidium ion transmembrane transporter activity | 9.929339e-3 |
GO:0048227 | plasma membrane to endosome transport | 9.929339e-3 |
GO:0010430 | fatty acid omega-oxidation | 9.929339e-3 |
GO:0035826 | rubidium ion transport | 9.929339e-3 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 9.929339e-3 |
GO:0032065 | cortical protein anchoring | 9.929339e-3 |
GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 1.024259e-2 |
GO:0071539 | protein localization to centrosome | 1.036188e-2 |
GO:0071233 | cellular response to leucine | 1.036188e-2 |
GO:0060339 | negative regulation of type I interferon-mediated signaling pathway | 1.036188e-2 |
GO:0034048 | negative regulation of protein phosphatase type 2A activity | 1.036188e-2 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 1.043292e-2 |
GO:0001963 | synaptic transmission, dopaminergic | 1.062614e-2 |
GO:0019363 | pyridine nucleotide biosynthetic process | 1.062806e-2 |
GO:0007091 | mitotic metaphase/anaphase transition | 1.083010e-2 |
GO:0047496 | vesicle transport along microtubule | 1.084464e-2 |
GO:0002513 | tolerance induction to self antigen | 1.101233e-2 |
GO:0035564 | regulation of kidney size | 1.107047e-2 |
GO:0043248 | proteasome assembly | 1.108682e-2 |
GO:0051972 | regulation of telomerase activity | 1.108682e-2 |
GO:0003062 | regulation of heart rate by chemical signal | 1.108682e-2 |
GO:0014053 | negative regulation of gamma-aminobutyric acid secretion | 1.123205e-2 |
GO:0071422 | succinate transmembrane transport | 1.123205e-2 |
GO:0033129 | positive regulation of histone phosphorylation | 1.123205e-2 |
GO:0016340 | calcium-dependent cell-matrix adhesion | 1.123205e-2 |
GO:0002003 | angiotensin maturation | 1.123205e-2 |
GO:0006481 | C-terminal protein methylation | 1.123205e-2 |
GO:0007144 | female meiosis I | 1.123205e-2 |
GO:0042147 | retrograde transport, endosome to Golgi | 1.132271e-2 |
GO:0021532 | neural tube patterning | 1.137807e-2 |
GO:0045833 | negative regulation of lipid metabolic process | 1.144440e-2 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 1.161821e-2 |
GO:0045930 | negative regulation of mitotic cell cycle | 1.170662e-2 |
GO:0070507 | regulation of microtubule cytoskeleton organization | 1.173042e-2 |
GO:0030952 | establishment or maintenance of cytoskeleton polarity | 1.186493e-2 |
GO:0072162 | metanephric mesenchymal cell differentiation | 1.186493e-2 |
GO:0072079 | nephron tubule formation | 1.197608e-2 |
GO:0021604 | cranial nerve structural organization | 1.209401e-2 |
GO:0007129 | synapsis | 1.226462e-2 |
GO:0002739 | regulation of cytokine secretion involved in immune response | 1.232118e-2 |
GO:0010721 | negative regulation of cell development | 1.234527e-2 |
GO:0051055 | negative regulation of lipid biosynthetic process | 1.237265e-2 |
GO:0010458 | exit from mitosis | 1.237848e-2 |
GO:0007088 | regulation of mitosis | 1.265500e-2 |
GO:0009586 | rhodopsin mediated phototransduction | 1.272446e-2 |
GO:0001880 | Mullerian duct regression | 1.272446e-2 |
GO:0007020 | microtubule nucleation | 1.288467e-2 |
GO:0002326 | B cell lineage commitment | 1.288467e-2 |
GO:0070842 | aggresome assembly | 1.293444e-2 |
GO:0043985 | histone H4-R3 methylation | 1.293444e-2 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.296251e-2 |
GO:0015931 | nucleobase-containing compound transport | 1.300257e-2 |
GO:0051865 | protein autoubiquitination | 1.310845e-2 |
GO:0050710 | negative regulation of cytokine secretion | 1.310845e-2 |
GO:0010470 | regulation of gastrulation | 1.313713e-2 |
GO:0006007 | glucose catabolic process | 1.314832e-2 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 1.315516e-2 |
GO:0032507 | maintenance of protein location in cell | 1.337070e-2 |
GO:0032353 | negative regulation of hormone biosynthetic process | 1.341915e-2 |
GO:0071843 | cellular component biogenesis at cellular level | 1.363934e-2 |
GO:0071243 | cellular response to arsenic-containing substance | 1.367136e-2 |
GO:2000543 | positive regulation of gastrulation | 1.384024e-2 |
GO:0072086 | specification of loop of Henle identity | 1.406998e-2 |
GO:0007099 | centriole replication | 1.406998e-2 |
GO:0006364 | rRNA processing | 1.425946e-2 |
GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity | 1.448791e-2 |
GO:0003241 | growth involved in heart morphogenesis | 1.451543e-2 |
GO:0051647 | nucleus localization | 1.452751e-2 |
GO:0070647 | protein modification by small protein conjugation or removal | 1.467229e-2 |
GO:0033044 | regulation of chromosome organization | 1.470232e-2 |
GO:0048268 | clathrin coat assembly | 1.475576e-2 |
GO:0003310 | pancreatic A cell differentiation | 1.475576e-2 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 1.484925e-2 |
GO:0040016 | embryonic cleavage | 1.485041e-2 |
GO:0006729 | tetrahydrobiopterin biosynthetic process | 1.485041e-2 |
GO:0002701 | negative regulation of production of molecular mediator of immune response | 1.514020e-2 |
GO:0048259 | regulation of receptor-mediated endocytosis | 1.527264e-2 |
GO:0035886 | vascular smooth muscle cell differentiation | 1.527462e-2 |
GO:0022904 | respiratory electron transport chain | 1.527462e-2 |
GO:0060486 | Clara cell differentiation | 1.549989e-2 |
GO:0065004 | protein-DNA complex assembly | 1.555359e-2 |
GO:0003166 | bundle of His development | 1.560187e-2 |
GO:0003218 | cardiac left ventricle formation | 1.567336e-2 |
GO:0021658 | rhombomere 3 morphogenesis | 1.570151e-2 |
GO:0006188 | IMP biosynthetic process | 1.570151e-2 |
GO:0043170 | macromolecule metabolic process | 1.575949e-2 |
GO:0031274 | positive regulation of pseudopodium assembly | 1.579727e-2 |
GO:0006659 | phosphatidylserine biosynthetic process | 1.579727e-2 |
GO:0006312 | mitotic recombination | 1.582729e-2 |
GO:0001845 | phagolysosome assembly | 1.582729e-2 |
GO:0021795 | cerebral cortex cell migration | 1.593598e-2 |
GO:0008334 | histone mRNA metabolic process | 1.612924e-2 |
GO:0006901 | vesicle coating | 1.612924e-2 |
GO:0070192 | chromosome organization involved in meiosis | 1.613861e-2 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 1.629023e-2 |
GO:0060816 | random inactivation of X chromosome | 1.629023e-2 |
GO:0006256 | UDP catabolic process | 1.629023e-2 |
GO:0045004 | DNA replication proofreading | 1.629023e-2 |
GO:2000657 | negative regulation of apolipoprotein binding | 1.629023e-2 |
GO:0043538 | regulation of actin phosphorylation | 1.629023e-2 |
GO:0010189 | vitamin E biosynthetic process | 1.629023e-2 |
GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific | 1.629023e-2 |
GO:0043046 | DNA methylation involved in gamete generation | 1.638171e-2 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 1.638171e-2 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 1.657030e-2 |
GO:0021522 | spinal cord motor neuron differentiation | 1.660885e-2 |
GO:0090102 | cochlea development | 1.664092e-2 |